Non-Invasive Respiratory Therapy Market to Reach USD 3.94 Billion by 2032, Driven by Growing Prevalence of Respiratory Disorders

Emergen Research reports that the global non-invasive respiratory therapy market, valued at USD 2.33 billion in 2022, is projected to grow at a steady compound annual growth rate (CAGR) of 5.3%, reaching USD 3.94 billion by 2032. The increasing incidence of respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD) is a primary factor contributing to this market expansion.

According to the American College of Allergy, Asthma & Immunology, asthma is one of the leading causes of hospitalizations, resulting in 439,000 cases annually in the U.S., with over 1.3 million emergency room visits. This chronic condition affects both children and adults, with children missing an estimated 13.8 million school days annually due to asthma, while adults lose around 14.2 million workdays. The economic toll of asthma is significant, estimated at USD 56 billion per year, further highlighting the urgent need for effective respiratory treatments.

Download Free Exclusive Sample PDF@ https://www.emergenresearch.com/request-sample/2378

However, the high costs associated with non-invasive respiratory devices present a challenge to market growth. Advanced technologies used in non-invasive ventilators drive up production costs, as manufacturers must adhere to strict quality and safety standards mandated by regulatory agencies such as the U.S. Food and Drug Administration (FDA). The requirement for customization to meet specific clinical needs also adds to the costs, making these therapies less accessible for some healthcare facilities and patients.

Key Segment Insights
In 2022, the non-invasive positive-pressure ventilator (PPV) segment accounted for the largest revenue share in the global market. Non-invasive PPV is effective for treating both acute and chronic respiratory failure by providing oxygen to the lungs without the need for invasive procedures like intubation. This technology is essential for patients with complex respiratory needs, allowing precise pressure adjustments during inhalation and exhalation to ensure optimal respiratory support.

The asthma and COPD segment is also expected to see rapid revenue growth over the forecast period. Non-invasive ventilation (NIV) has transformed the treatment of respiratory failure in critical patients, offering a lifesaving alternative to invasive mechanical ventilation. Particularly for patients with conditions like COPD exacerbations and acute cardiogenic pulmonary edema, NIV can reduce the need for intubation, lower mortality rates, and relieve pressure on fatigued respiratory muscles.

Interested in knowing more relevant information? Click here: https://www.emergenresearch.com/industry-report/non-invasive-respiratory-therapy-market

Regional Insights
North America is anticipated to hold the largest revenue share of the non-invasive respiratory therapy market over the forecast period, driven by high rates of respiratory disorders and ongoing advancements in healthcare technology. Increasing healthcare expenditure and strong demand for innovative respiratory therapies are also expected to support market growth in the region.

Key Market Players and Recent Developments
Leading companies in the non-invasive respiratory therapy market include ResMed Inc., Teleflex Incorporated, Hamilton Medical, Koninklijke Philips N.V., and Fisher & Paykel Healthcare Limited, among others. These organizations play a pivotal role in advancing respiratory care through technology and innovation.

In a recent development, Inspiration Healthcare Group plc, a global medical technology company, announced in March 2023 the expansion of its neonatal ventilator line with the introduction of three new versions of its SLE6000 ventilator. These advanced models are designed to provide precise, non-invasive respiratory support for critically ill newborns in high dependency care settings, demonstrating the company's commitment to addressing the specific needs of vulnerable patients.

Emergen Research has segmented the global non-invasive respiratory therapy market on the basis of product, application, end-use, and region:

Product Outlook (Revenue, USD Billion; 2019-2032)
Non-invasive Positive-pressure Ventilator (PPV)
Bi-level Positive Airway Pressure Ventilator (BiPAP)
Constant Positive Airway Pressure Ventilator (CPAP)
Autotitrating (Adjustable) Positive Airway Pressure Ventilator (APAP)
Non-invasive Negative-pressure Ventilator (PPV)

Application Outlook (Revenue, USD Billion; 2019-2032)
Respiratory Distress Syndrome
Asthma & Chronic Obstructive Pulmonary Disease (COPD)
Others

End-use Outlook (Revenue, USD Billion; 2019-2032)
Hospitals
Ambulatory Surgical Centers (ASCs)
Others

Make Payment [Buy your Exclusive copy] @ https://www.emergenresearch.com/select-license/2378

The global non-invasive respiratory therapy market is set to grow steadily as respiratory disorders continue to impact a significant portion of the population. Advances in non-invasive respiratory technology are expected to play a crucial role in meeting the demand for effective and accessible respiratory care solutions, benefiting patients worldwide and driving the overall market forward.

14671 110 Avenue, Surrey, British Columbia, V3R2A9
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.